The weekly update from Oncology Central
arrived today. Like much of their stuff it is more “peripheral interest”
than “directly relevant” for me. But all useful stuff…
Editor's pick |
 |
Looking to the future of immunotherapy in cancer treatment
Find out about patient-focused solutions such as immune-cell engagers and next-generation cell therapies in our latest opinion article.
This article was sponsored by AstraZeneca. |
Latest articles |
 |
Tooth be told: regular dental check-ups impact head and neck cancer survival rates
An international study has revealed a significant association between oral health and survival rates among individuals diagnosed with head and neck cancer. |
 |
How maternal instinct led researchers to the latest breast cancer detection tool
Discover further details about the groundbreaking research in our indepth news article, which highlights that a “breast milk liquid biopsy” may be a valuable tool in the early detection of breast cancer. |
 |
The JAVELIN Bladder Medley trial is assessing whether avelumab maintenance treatment in combination with other anticancer drugs can help people with advanced urothelial cancer live longer and have a longer time without their cancer getting worse compared with avelumab alone. |
No comments:
Post a Comment